secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2026-07-24T11:45:42+00:00
Accession:  0001193125-26-315151
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q2 revenue $20.23B (+8.7%), EPS $7.62 (+11.6%); declares $0.78 dividend
--------------------------------------------------------------------------------

- Revenue $20.23B (+8.7% YoY); net income $1.699B (+2.8%); diluted EPS $7.62 (+11.6%).
- Adjusted EBITDA $4.027B (+4.6%); same facility admissions +2.5%, equivalent admissions +2.7%.
- Payer mix shift from uninsured volume had ~$400M unfavorable pre-tax impact; offset by ~$400M net benefit from Medicaid Supplemental Payment Programs (Florida).
- Cash flows from operations $2.335B vs $4.210B in prior year (down 44.5%).
- Board declared quarterly dividend $0.78/share, payable Sept 30, 2026 to holders of record Sept 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/0001193125-26-315151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/hca-20260724.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-315151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer